Quick Answer
SPRUCE BIOSCIENCES, INC. reported Net Income Loss of -$38.97 million for the year ending 2025.
- SPRUCE BIOSCIENCES, INC. showed an increase of +26.5% in Net Income Loss from 2024 to 2025.
- This data is from SPRUCE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$4.12 million | Q2 2019: -$3.24 million | Q3 2019: -$2.55 million | Q1 2020: -$5.17 million | Q2 2020: -$6.45 million | Q3 2020: -$9.59 million | Q1 2021: -$9.89 million | Q2 2021: -$11.77 million | Q3 2021: -$11.45 million | Q1 2022: -$11.76 million | Q2 2022: -$11.87 million | Q3 2022: -$11.40 million | Q1 2023: -$12.79 million | Q2 2023: -$12.82 million | Q3 2023: -$12.35 million | Q1 2024: -$11.63 million | Q2 2024: -$9.18 million | Q3 2024: -$8.67 million | Q1 2025: -$14.04 million | Q2 2025: -$2.07 million | Q3 2025: -$8.21 million.
- Over the full 7 years of available data (2019 to 2025), SPRUCE BIOSCIENCES, INC.'s Net Income Loss has declined by 197.7%.
- Historical annual values: Fiscal year 2025: -$38.97 million | Fiscal year 2024: -$53.04 million | Fiscal year 2023: -$47.92 million | Fiscal year 2022: -$46.18 million | Fiscal year 2021: -$42.29 million | Fiscal year 2020: -$29.54 million | Fiscal year 2019: -$13.09 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: